URGENT: This Altcoin Opportunity Won’t Wait – Act Now

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Andrew Snyder Biography and Net Worth

Director of Clarivate

Mr. Andrew Snyder is the Director of Clarivate.

What is Andrew Miles Snyder's net worth?: The estimated net worth of Andrew Miles Snyder is at least $1.44 million as of August 8th, 2024. Mr. Snyder owns 288,334 shares of Clarivate stock worth more than $1,435,903 as of December 21st. This net worth evaluation does not reflect any other assets that Mr. Snyder may own. Learn More about Andrew Miles Snyder's net worth.
How do I contact Andrew Miles Snyder?: The corporate mailing address for Mr. Snyder and other Clarivate executives is 160 Blackfriars Road, London X0, SE1 8EZ. Clarivate can also be reached via phone at 442074334000 and via email at [email protected]. Learn More on Andrew Miles Snyder's contact information.
Has Andrew Miles Snyder been buying or selling shares of Clarivate?: Andrew Miles Snyder has not been actively trading shares of Clarivate during the past quarter. Most recently, on Thursday, August 8th, Andrew Miles Snyder bought 28,938 shares of Clarivate stock. The stock was acquired at an average cost of $5.49 per share, with a total value of $158,869.62. Following the completion of the transaction, the director now directly owns 288,334 shares of the company's stock, valued at $1,582,953.66. Learn More on Andrew Miles Snyder's trading history.
Who are Clarivate's active insiders?: Clarivate's insider roster includes Mukhtar Ahmed (Insider), Richard Hanks (CFO), Richard Roedel (Director), Saurabh Saha (Director), James Samson (Insider), Andrew Snyder (Director), Bar Veinstein (Insider), and Sheryl von Bluchder (Director). Learn More on Clarivate's active insiders.
Are insiders buying or selling shares of Clarivate?: In the last year, Clarivate insiders bought shares 3 times. They purchased a total of 2,293,938 shares worth more than $11,794,219.62. In the last year, insiders at the sold shares 3 times. They sold a total of 197,646 shares worth more than $1,379,110.50. The most recent insider tranaction occured on November, 22nd when Director Michael J Angelakis bought 765,000 shares worth more than $3,970,350.00. Insiders at Clarivate own 23.1% of the company. Learn More about insider trades at Clarivate.
Information on this page was last updated on 11/22/2024.

Andrew Miles Snyder Insider Trading History at Clarivate

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/8/2024	Buy	28,938	$5.49	$158,869.62	288,334
9/14/2022	Buy	208,333	$11.61	$2,418,746.13	208,333

Andrew Miles Snyder Buying and Selling Activity at Clarivate

Clarivate Company Overview

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

Today's Range

Now: $4.98

$4.82

$5.07

50 Day Range

MA: $5.68

$4.33

$6.83

2 Week Range

Now: $4.98

$4.25

$9.60

Volume

6,610,482 shs

Average Volume

4,601,417 shs

Market Capitalization

$3.54 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.12

From Behind the Markets | Ad

My research indicates there is only one investment that can meet AI's unprecedented demand for energy.

Click to get the name and ticker symbol